RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α

被引:412
作者
Liu, Ye V.
Baek, Jin H.
Zhang, Huafeng
Diez, Roberto
Cole, Robert N.
Semenza, Gregg L. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Inst Genet Engn, Vasc Biol Program, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, McKuisck Nathans Inst Genet Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[7] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA
关键词
D O I
10.1016/j.molcel.2007.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia-inducible factor 1 (HIF-1) regulates transcription in response to changes in 02 concentration. O-2-dependent degradation of the HIF-1 a subunit is mediated by prolyl hydroxylase (PHD), the von Hippel-Lindau (VHL)/Elongin-C/Elongin-B E3 ubiquitin ligase complex, and the proteasome. Inhibition of heat-shock protein 90 (HSP90) leads to O-2/PHDNHL-independent degradation of HIF-1 . We have identified the receptor of activated protein kinase C (RACK1) as a HIF-1 alpha-interacting protein that promotes PHD/VHL-independent proteasomal degradation of HIF-1 alpha. RACK1 competes with HSP90 for binding to the PAS-A domain of HIF-1 alpha in vitro and in human cells. HIF-1 alpha degradation induced by the HSP90 inhibitor 17-allyl-aminogeldanamycin is abolished by RACK1 loss of function. RACK1 binds to Elongin-C and promotes ubiquitination of HIF-1 alpha. Elongin-C-binding sites in RACK1 and VHL show significant sequence similarity. Thus, RACK1 is an essential component of an O-2/PHD/VHL-independent mechanism for regulating HIF-loc stability through competition with HSP90 and recruitment of the Elongin-C/B ubiquitin ligase complex.
引用
收藏
页码:207 / 217
页数:11
相关论文
共 50 条
[1]   OS-9 interacts with hypoxia-inducible factor 1α and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α [J].
Baek, JH ;
Mahon, PC ;
Oh, J ;
Kelly, B ;
Krishnamachary, B ;
Pearson, M ;
Chan, DA ;
Giaccia, AJ ;
Semenza, GL .
MOLECULAR CELL, 2005, 17 (04) :503-512
[2]   HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia [J].
Berra, E ;
Benizri, E ;
Ginouvès, A ;
Volmat, V ;
Roux, D ;
Pouysségur, J .
EMBO JOURNAL, 2003, 22 (16) :4082-4090
[3]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[4]   Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly [J].
Ceci, M ;
Gaviraghi, C ;
Gorrini, C ;
Sala, LA ;
Offenhäuser, N ;
Marchisio, PC ;
Biffo, S .
NATURE, 2003, 426 (6966) :579-584
[5]   Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition -: The role of HIF-1α, HIF-2α, and other pathways [J].
Elvidge, Gareth P. ;
Glenny, Louisa ;
Appelhoff, Rebecca J. ;
Ratcliffe, Peter J. ;
Ragoussis, Jiannis ;
Gleadle, Jonathan M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (22) :15215-15226
[6]   C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation [J].
Epstein, ACR ;
Gleadle, JM ;
McNeill, LA ;
Hewitson, KS ;
O'Rourke, J ;
Mole, DR ;
Mukherji, M ;
Metzen, E ;
Wilson, MI ;
Dhanda, A ;
Tian, YM ;
Masson, N ;
Hamilton, DL ;
Jaakkola, P ;
Barstead, R ;
Hodgkin, J ;
Maxwell, PH ;
Pugh, CW ;
Schofield, CJ ;
Ratcliffe, PJ .
CELL, 2001, 107 (01) :43-54
[7]   RACK1 and stratifin target ΔNp63α for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage [J].
Fomenkov, A ;
Zangen, R ;
Huang, YP ;
Osada, M ;
Guo, ZM ;
Fomenkov, T ;
Trink, B ;
Sidransky, D ;
Ratovitski, EA .
CELL CYCLE, 2004, 3 (10) :1285-1295
[8]  
Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO
[9]  
2-6
[10]  
Gradin K, 1996, MOL CELL BIOL, V16, P5221